101 related articles for article (PubMed ID: 17414572)
1. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
Newall F; Browne M; Savoia H; Campbell J; Barnes C; Monagle P
J Pediatr Hematol Oncol; 2007 Apr; 29(4):269-73. PubMed ID: 17414572
[TBL] [Abstract][Full Text] [Related]
2. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
4. [Thrombolytic therapy using a low dose of tissue plasminogen activator in children].
Santiago MJ; López-Herce J; Zarzoso S; Sánchez A; Mencía S; Carrillo A
An Pediatr (Barc); 2012 Feb; 76(2):77-82. PubMed ID: 21982548
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
6. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis in newborns and infants.
Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
[TBL] [Abstract][Full Text] [Related]
8. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
[TBL] [Abstract][Full Text] [Related]
11. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter.
O'Sullivan GJ; Lohan DG; Gough N; Cronin CG; Kee ST
J Vasc Interv Radiol; 2007 Jun; 18(6):715-24. PubMed ID: 17538133
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of recombinant tissue plasminogen activator for venous thrombosis after paediatric heart surgery.
Justice LB; Nelson DP; Palumbo J; Sawyer J; Patel MN; Byrnes JW
Cardiol Young; 2018 Feb; 28(2):214-221. PubMed ID: 28889818
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
14. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study.
De Santis A; Moscatelli R; Catalano C; Iannetti A; Gigliotti F; Cristofari F; Trapani S; Attili AF
Dig Liver Dis; 2010 Jun; 42(6):451-5. PubMed ID: 19819770
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
Smalberg JH; Spaander MV; Jie KS; Pattynama PM; van Buuren HR; van den Berg B; Janssen HL; Leebeek FW
Thromb Haemost; 2008 Dec; 100(6):1084-8. PubMed ID: 19132234
[TBL] [Abstract][Full Text] [Related]
16. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis.
Darbari DS; Desai D; Arnaldez F; Desai K; Kallen J; Strouse J; Streiff MB; Hong K; Takemoto CM
Br J Haematol; 2012 Nov; 159(3):376-8. PubMed ID: 22934795
[No Abstract] [Full Text] [Related]
18. Deep vein thrombosis of lower extremity: direct intraclot injection of alteplase once daily with systemic anticoagulation--results of pilot study.
Chang R; Chen CC; Kam A; Mao E; Shawker TH; Horne MK
Radiology; 2008 Feb; 246(2):619-29. PubMed ID: 18227550
[TBL] [Abstract][Full Text] [Related]
19. [Catheter-directed thrombolysis of iliofemoral venous thrombosis].
Ly B; Njaastad AM; Sandbaek G; Solstrand R; Rosales A; Slagsvold CE
Tidsskr Nor Laegeforen; 2004 Feb; 124(4):478-80. PubMed ID: 14983192
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
